NEW YORK, N.Y. and LONDON, U.K. — Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on Making the Right Research Decision for ROI - The Link Between Research and Decisions on Bottom Line Return.

NEW YORK, N.Y. and LONDON, U.K. — Costing the global pharmaceutical industry an estimated $30 billion per year and causing an estimated 125,000 deaths per year in the United States, patient non-adherence is a looming issue in the healthcare industry. Eularis has responded to this problem with a new report, available today, titled, “Ensuring Profitable Patient Adherence Programs.”

NEW YORK, N.Y. and LONDON, U.K. — Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on meeting the challenges of measuring ROI within the changing dynamics of the pharma industry. On Wednesday 26 March 2008, Dr. Bates will deliver a presentation titled, “Are You Up to the Challenge of Measuring ROI in Changing Dynamics of the Pharma Industry?”

TEMPE, Ariz. — Superbowl quarterback, Tom Brady has agreed to be the face of Myo-Med, for the launch of their 2008 media campaign. BioForce, the makers of Myo-Med, recently appointed STG Media Corp. as their agency of record to assist them in creating brand awareness among athletes and arthritis sufferers nationwide.

NEW YORK, N.Y. — Brand teams at a leading New York healthcare communications group are taking their digital skills to the next level at a day-long Tech Fit fair on Tuesday, February 12, 2008, at Saatchi & Saatchi Healthcare Communications Group (SSHCG) headquarters in lower Manhattan. According to Sam Welch, SSHCG president, “Tech Fit isn’t the usual show and tell one-off. It is the latest innovation in SSHCG’s ongoing program of digital training.”

NEW YORK, N.Y. and LONDON, U.K. — Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on marketing return at the Pharmaceutical Marketing Society Half-day Conference: ROI or RIP. At 2:30 p.m. on Monday 26 November 2007, Dr. Bates will deliver a presentation titled, “What Can Be Measured?”

LONDON, U.K. — Eularis is announcing the release of an update to its report, “Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line.” Originally offered in February 2007, the comprehensive report has been revised to provide pharmaceutical marketers with a competitive edge and the latest research information.

NEW YORK, N.Y. and LONDON, U.K. — Campbell Belman, an established pharmaceutical analytics company, today introduces its new name: Eularis. This announcement reflects the significant growth the Company has achieved across its full range of pharmaceutical analytics products, which have helped tailor the advertising and marketing programs of its global top-tier clients.